Lexington, MA, United States of America

Kim Askew

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kim Askew: Innovator in Genetic Treatments

Introduction

Kim Askew is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of genetic treatments, particularly in addressing ornithine transcarbamylase deficiency. With a total of two patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Kim Askew's latest patents focus on the composition and methods for the treatment of ornithine transcarbamylase deficiency. The inventions provide methods for treating this condition by administering a composition that includes an mRNA encoding an ornithine transcarbamylase protein. This treatment is designed to be given at a low dose and at specific intervals to effectively reduce symptoms associated with the deficiency.

Career Highlights

Kim Askew is currently associated with Translate Bio, Inc., where she continues to develop groundbreaking treatments. Her expertise in genetic therapies has positioned her as a key figure in the biotechnology sector.

Collaborations

Throughout her career, Kim has collaborated with notable colleagues, including Jou-Ku Chung and Frank DeRosa. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Kim Askew's work exemplifies the impact of innovation in the field of genetic treatments. Her patents and collaborations reflect her commitment to improving health outcomes for individuals with genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…